GlassScriptPhysician profile
Sejal Amin
NPI 1013337443
$1,061.06
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $61.92 · 2021: $119 · 2022: $403 · 2023: $94.67 · 2024: $81.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.13 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $92.12 | 2019-2020 | |
| Coopersurgical, INC. | $87.88 | 2019-2024 | Paragard T 380a |
| Exeltis, USA INC. | $84.27 | 2019-2024 | Slynd |
| Allergan, INC. | $68.26 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $59.93 | 2021-2023 | |
| Scynexis, INC. | $46.58 | 2022 | |
| Evofem Biosciences, INC. | $42.78 | 2021-2022 | |
| Therapeuticsmd, INC. | $39.92 | 2019-2022 | |
| Avanos Medical | $38.91 | 2019 | |
| Celularity INC. | $38.00 | 2019 | |
| Myovant Sciences INC. | $32.75 | 2022 | |
| Astellas Pharma US INC | $29.09 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $28.57 | 2019-2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $26.45 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $18.10 | 2022 | |
| Avion Pharmaceuticals | $14.22 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.76 | 2019 | |
| Agile Therapeutics, INC. | $12.96 | 2022 | |
| Organon LLC | $7.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sejal Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.